EarningsQ3 2022 Earnings Report

AbbVie (ABBV) Q3 2022 Earnings Report

0 Followers

MX:ABBV Q3 2022 EPS Results

Actual EPS$66.53

Consensus EPS$64.95

Beat/MissBeat by +$1.58

One Year Ago EPS$60.53

Actual Revenue$269.26B

Expected Revenue$271.95B

Beat/MissMissed by -$2.69B

YoY Revenue Growth+3.28%

QuarterQ3 2022

Date10/28/2022

TimeBefore Open

Conference CallFriday, October 28, 2022

MX:ABBV Upcoming Earnings

AbbVie's next earnings date is estimated for October 30, 2026, based on past reporting schedules.

MX:ABBV Q3 2022 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 30, 2026	2026 (Q3)	70.15 / -	33.811	―
Jul 31, 2026	2026 (Q2)	65.53 / 66.35	53.989	22.90% (+12.36)
Apr 29, 2026	2026 (Q1)	47.12 / 48.17	44.718	7.72% (+3.45)
Feb 04, 2026	2025 (Q4)	48.23 / 49.26	39.265	25.46% (+10.00)
Oct 31, 2025	2025 (Q3)	32.10 / 33.81	54.535	-38.00% (-20.72)
Jul 31, 2025	2025 (Q2)	52.35 / 53.99	48.172	12.08% (+5.82)
Apr 25, 2025	2025 (Q1)	43.25 / 44.72	41.992	6.49% (+2.73)
Jan 31, 2025	2024 (Q4)	38.45 / 39.26	50.717	-22.58% (-11.45)
Oct 30, 2024	2024 (Q3)	53.08 / 54.53	53.626	1.69% (+0.91)
Jul 25, 2024	2024 (Q2)	46.65 / 48.17	52.899	-8.93% (-4.73)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed